Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05037708
Other study ID # Fisioterapia en Linfedema
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2022
Est. completion date October 27, 2022

Study information

Verified date April 2023
Source University of Vigo
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Lymphedema related to breast cancer is one of the main complications after breast cancer treatment. Manual lymphatic drainage appears as a technique which could be applied in the treatment of lymphedema along with other techniques. The aim of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage on the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a randomized, blinded, crossover clinical trial is suggested to assess the effect of an intensive physiotherapy intervention on the treatment of lymphedema in its maintenance phase, in comparison with a control group without physiotherapy treatment. The cytometry, displaced water volume, thickness of the lymphedema with ultrasound, dynamometry and sensation of heaviness, pain and tension of the upper limb will be evaluated.


Description:

Complex decongestant therapy is a set of techniques which seek the treatment of lymphedema in a conservative way as described in the recent international consensus of the International Lymphology Society, published in 2020. Complex decongestant therapy in a first phase aims to reduce cutaneous edema and in a second phase it aims to preserve and optimize the results obtained. The first phase consists of skin care, manual lymphatic drainage, muscle pumping exercises, and compression techniques, typically applied with multilayer bandages. The second phase consists of compression with low elasticity, skin care exercises, and repeated manual lymphatic drainage as needed. The frequency and intensity of components of complex decongestant therapy in phase I and II should depend on the clinical findings of edema and the stage of lymphedema and could be adapted to clinical changes. Note that phase II or stabilization represents long-term therapy over many years and in the case of deterioration of edema, phase I of complex decongestant therapy may need to be repeated. In recent years, there is debate about the efficacy of manual lymphatic drainage. Sometimes it is not prescribed, being replaced by the recommendation of a self-massage. Furthermore, complex decongestant therapy was suggested to be time consuming, expensive and difficult to tolerate, and does not improve lymphatic function. In contrast, researchers such as Müller et al., in 2018, state that it is a well-tolerated and safe treatment technique, demonstrating benefits in reducing edema. Other research has also shown that manual lymphatic drainage is effective both on a preventive level and as a postoperative rehabilitation treatment, having optimal results when combined with the other elements of complex decongestant therapy. A recent systematic review published in 2020 highlights the need of more experimental studies on the effectiveness of manual lymphatic drainage on lymphedema. Thus, the purpose of this study is to analyze the effects of a physiotherapy program based on manual lymphatic drainage in the treatment of lymphedema after breast cancer, during the stabilization or maintenance phase of complex decongestant therapy. Therefore, a double-blind crossover clinical trial is proposed.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date October 27, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria: - Women included in the lymphedema treatment maintenance program through the Galician Lymphedema Association - Women with secondary unilateral lymphedema after breast cancer Exclusion Criteria: - Women undergoing chemotherapy or radiotherapy treatment. - Severe systemic or neurological disease

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Manual lymphatic drainage
Subjects are randomly assigned to group 1. Group 1 receives treatment A* for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment B** was applied to group 1 for 4 weeks. *Treatment A consists of manual lymphatic drainage. **Treatment B consists of no treatment
Manual lymphatic drainage
Subjects are randomly assigned to group 2. Group 2 receives treatment B** for 4 weeks. Afterwards, a period of washing or bleaching should be allowed in order to be sure that the effects of the intervention have disappeared. This period will last 2 months during which the usual treatment for LGA patients will be carried out, which consists of 2 monthly physiotherapy sessions, in this way it is intended that the subjects are in the initial state (as before the start of the first intervention). After this washout period, treatment A* was applied to group 2 for 4 weeks. *Treatment A consists of manual lymphatic drainage. **Treatment B consists of no treatment

Locations

Country Name City State
Spain Faculty of Physiotherapy Pontevedra

Sponsors (2)

Lead Sponsor Collaborator
University of Vigo Asociación Gallega de Linfedema

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary circometry measurement of upper limb perimeters 1 day
Primary circometry measurement of upper limb perimeters 1 month
Primary circometry measurement of upper limb perimeters 3 month
Primary circometry measurement of upper limb perimeters 4 month
Primary Volumetry by water displacement weight of water extravasated when introducing the upper limb into a container with water 1 day
Primary Volumetry by water displacement weight of water extravasated when introducing the upper limb into a container with water 1 month
Primary Volumetry by water displacement weight of water extravasated when introducing the upper limb into a container with water 3 month
Primary Volumetry by water displacement weight of water extravasated when introducing the upper limb into a container with water 4 month
Primary Measurement of edema thickness by ultrasound measurement of subcutaneous tissue thickness 1 day
Primary Measurement of edema thickness by ultrasound measurement of subcutaneous tissue thickness 1 month
Primary Measurement of edema thickness by ultrasound measurement of subcutaneous tissue thickness 3 month
Primary Measurement of edema thickness by ultrasound measurement of subcutaneous tissue thickness 4 month
Secondary Assessment of the sensation of heaviness Visual analogic scale 1 day
Secondary Assessment of the sensation of heaviness Visual analogic scale 1 month
Secondary Assessment of the sensation of heaviness Visual analogic scale 3 month
Secondary Assessment of the sensation of heaviness Visual analogic scale 4 month
Secondary Assessment of the sensation of pain Visual analogic scale 1 day
Secondary Assessment of the sensation of pain Visual analogic scale 1 month
Secondary Assessment of the sensation of pain Visual analogic scale 3 month
Secondary Assessment of the sensation of pain Visual analogic scale 4 month
Secondary Assessment of the sensation of tension in the upper limb Visual analogic scale 1 day
Secondary Assessment of the sensation of tension in the upper limb Visual analogic scale 1 month
Secondary Assessment of the sensation of tension in the upper limb Visual analogic scale 3 month
Secondary Assessment of the sensation of tension in the upper limb Visual analogic scale 4 month
Secondary dynamometry Assessment of muscle grip strength by dynamometry 1 day
Secondary dynamometry Assessment of muscle grip strength by dynamometry 1 month
Secondary dynamometry Assessment of muscle grip strength by dynamometry 3 month
Secondary dynamometry Assessment of muscle grip strength by dynamometry 4 month
See also
  Status Clinical Trial Phase
Terminated NCT04858230 - LymphoPilot Test for Limb Lymphedema N/A
Completed NCT04575636 - MRL in the Upper Extremity N/A
Completed NCT03252145 - Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device N/A
Active, not recruiting NCT05441943 - Lymphaticovenous Anastomosis as Treatment for Lymphedema N/A
Completed NCT05754346 - Does Inclusion of Diaphragmatic Breathing Exercises in Complete Decongestive Therapy Provide Further Benefits in Patients With Breast Cancer Related Lymphedema N/A
Not yet recruiting NCT06264817 - Auto-Adjustable MOBIDERm Autofit Armsleeve in the Management of Upper Limb Lymphedema. N/A
Completed NCT06399458 - The Relationship Between Primary Lymphedema and Joint Hypermobility
Recruiting NCT06302361 - Lymphovenous Anastomosis for Breast Cancer Lymphedema N/A
Active, not recruiting NCT06278298 - Different Level of ECSWT in Post Mastectomy Lymphedema N/A
Not yet recruiting NCT02453295 - Testing an Intervention to Foster Hope for Cancer Survivors With Lymphedema N/A
Completed NCT05660590 - Effect of Different Bandage Interface Pressures on Breast Cancer Related Lymphedema N/A
Withdrawn NCT02458391 - Complete Decongestive Therapy in Breast Cancer-Related Lymphedema N/A
Completed NCT04766489 - Evaluation of the Treatment Response in Breast Cancer Related Lymphedema N/A
Enrolling by invitation NCT04165512 - Effectiveness of Stellate Ganglion Block in Breast Cancer Related Lymphedema N/A
Recruiting NCT05762224 - Comparative Effects of KT and PG on UE Lymphedema and Functional Disability After Mastectomy N/A
Recruiting NCT06082349 - The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema N/A
Recruiting NCT05142800 - Screening For BCRL In Targeted Therapy For Breast Cancer
Recruiting NCT06012786 - Myofascial Pain Syndrome in Patients With Breast Cancer-related Lymphedema
Not yet recruiting NCT06113627 - Lymphatic Response to Resistance Exercise in Breast Cancer Survivors N/A
Completed NCT06036173 - Body Awareness and Functionality in Lymphedema